SMYD2 and acute kidney injury: In this study, we investigated the effect of SMYD2 inhibition on the development of AKI induced by cisplatin in a mouse model by using AZ505, a substrate-competitive inhibitor that binds the peptide-bind in groove of SMYD2 to reduce its methyltransferase activity (Ferguson et al., 2011).